Genomic Evaluation of Multiparametric Magnetic Resonance Imaging-visible and -nonvisible Lesions in Clinically Localised Prostate Cancer

BACKGROUND: The prostate cancer (PCa) diagnostic pathway is undergoing a radical change with the introduction of multiparametric magnetic resonance imaging (mpMRI), genomic testing, and different prostate biopsy techniques. It has been proposed that these tests should be used in a sequential manner...

Descripción completa

Detalles Bibliográficos
Autores principales: Parry, Marina A., Srivastava, Shambhavi, Ali, Adnan, Cannistraci, Alessio, Antonello, Jenny, Barros-Silva, João Diogo, Ubertini, Valentina, Ramani, Vijay, Lau, Maurice, Shanks, Jonathan, Nonaka, Daisuke, Oliveira, Pedro, Hambrock, Thomas, Leong, Hui Sun, Dhomen, Nathalie, Miller, Crispin, Brady, Ged, Dive, Caroline, Clarke, Noel W., Marais, Richard, Baena, Esther
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6472613/
https://www.ncbi.nlm.nih.gov/pubmed/30929837
http://dx.doi.org/10.1016/j.euo.2018.08.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6472613/
https://www.ncbi.nlm.nih.gov/pubmed/30929837
http://dx.doi.org/10.1016/j.euo.2018.08.005

Ejemplares similares